Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medipharm Labs Corp (LABS.TO)

Medipharm Labs Corp (LABS.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 328,227
  • Shares Outstanding, K 129,759
  • Annual Sales, $ 10,198 K
  • Annual Income, $ -8,386 K
  • 60-Month Beta N/A
  • Price/Sales 7.68
  • Price/Cash Flow N/A
  • Price/Book 2.54
  • Price/Earnings ttm 10.91
  • Earnings Per Share ttm 0.23
  • Most Recent Earnings 0.02 on 09/30/19
  • Next Earnings Date 03/30/20
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.00
  • Number of Estimates 1
  • High Estimate 0.00
  • Low Estimate 0.00
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.19 +14.61%
on 02/28/20
3.35 -25.07%
on 02/20/20
-0.73 (-22.53%)
since 01/28/20
3-Month
2.19 +14.61%
on 02/28/20
4.44 -43.47%
on 01/16/20
-1.42 (-36.13%)
since 11/28/19
52-Week
2.19 +14.61%
on 02/28/20
7.39 -66.04%
on 05/14/19
-0.47 (-15.77%)
since 02/28/19

Most Recent Stories

More News
CannabisNewsBreaks - technical420 Highlights Five "Need-to-Know" Price Target Changes for Cannabis Investors

A recent editorial by Anthony Varrell on titled "5 Price Target Changes Cannabis Investors Need To Know" reviews five rating or price target changes by leading broker-dealers that were announced in January....

SMG : 105.99 (-4.32%)
WEED.TO : 25.17 (-1.06%)
CGC : 18.78 (+1.84%)
LABS.TO : 2.51 (+1.62%)
MEDIF : 1.9000 (+7.34%)
ACB.TO : 1.81 (-7.18%)
ACB : 1.34 (-7.59%)
HITI.CN : 0.150 (-6.25%)
HITIF : 0.1139 (-0.44%)
MediPharm Labs Appoints New Chief Financial Officer

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company") a global leader in specialized, research-driven cannabis extraction, distillation and purification, is pleased...

PEP : 132.03 (-3.18%)
LABS.TO : 2.51 (+1.62%)
MEDIF : 1.9000 (+7.34%)
Canada Legalizes Cannabis Edibles, Beverages, Extracts and Other Derivative Products

On the first anniversary of Canadian cannabis legalization, "Legalization 2.0" or "Cannabis 2.0" will allow popular cannabis derivatives like edibles, infused beverages, and vapes to legally be bought...

LABS.TO : 2.51 (+1.62%)
MEDIF : 1.9000 (+7.34%)
CRON.TO : 7.79 (-4.30%)
CRON : 5.85 (-2.99%)
VGW.VN : 3.100 (+1.64%)
VGWCF : 2.3040 (-3.19%)
IAN.CN : 1.130 (unch)
ITHUF : 0.8479 (+1.24%)
BEV.CN : 0.330 (-19.51%)
BVNNF : 0.2465 (-15.00%)
MediPharm Labs Corp. Presenting at the Benzinga Cannabis Capital Conference in Chicago

Chicago, Illinois--(Newsfile Corp. - October 15, 2019) - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ), will be presenting at the 5th Benzinga Cannabis Capital Conference in Chicago October...

CBCA : 0.7500 (unch)
LABS.TO : 2.51 (+1.62%)
MEDIF : 1.9000 (+7.34%)
MediPharm Labs Announces Participation at Upcoming BMO & TMX Hemp & Medical Cannabis Conference in London, UK

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company") a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid...

ACB.TO : 1.81 (-7.18%)
LABS.TO : 2.51 (+1.62%)
MEDIF : 1.9000 (+7.34%)
MediPharm Labs and Cronos Group Enter Private Label Contract Manufacturing Agreement

-- Deal reinforces MediPharm Labs' leadership in large scale manufacturing and distribution

LABS.TO : 2.51 (+1.62%)
MEDIF : 1.9000 (+7.34%)
CRON : 5.85 (-2.99%)
CRON.TO : 7.79 (-4.30%)
MediPharm Labs Corp. Opens the Market

TORONTO , Aug. 14, 2019 /CNW/ - Patrick McCutcheon , CEO, MediPharm Labs Inc. (LABS), joined Steven Mills , Head, Company Services, Toronto Stock Exchange and TSX Venture Exchange, to open...

LABS.TO : 2.51 (+1.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

2nd Resistance Point 2.80
1st Resistance Point 2.66
Last Price 2.51
1st Support Level 2.28
2nd Support Level 2.04

See More

52-Week High 7.39
Fibonacci 61.8% 5.40
Fibonacci 50% 4.79
Fibonacci 38.2% 4.18
Last Price 2.51
52-Week Low 2.19

See More

Business Summary

MediPharm Labs Corp has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulation without first receiving a cannabis cultivation license. The focus on cannabis concentrates from current Good...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar